Clinical Trials in Portland

Showing 6181-6200 of 10,048 trials

Treatment of Chronic Stroke With AMES + EMG Biofeedback

NCT01116544

The purpose of this study is to determine if individuals who had a stroke more than one year before entering the study and who remain unable to open their affected hand are better able to sense and move their affected arm after 10-15 weeks of treatment with a new robotic therapy device (the AMES device) and EMG biofeedback.

StrokePlegiaParesis+1 more

AMES Technology46 participantsStarted Sep 2007

Atlanta, Georgia, United States • Chicago, Illinois, United States • Portland, Oregon, United States

COMPLETEDPhase 3< 1 mile

A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

NCT02095158

This study will evaluate the long-term safety and efficacy of oxymetazoline hydrogen chloride (HCL) Cream 1.0% (AGN-199201) in patients with persistent erythema associated with rosacea.

ErythemaRosacea

Allergan440 participantsStarted Apr 2014

Portland, Oregon, United States

COMPLETEDPhase 2< 1 mile

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

NCT03018340

To assess the efficacy of pimavanserin compared to placebo when given adjunctively to a selective serotonin reuptake inhibitor (SSRI)/serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant as treatment of patients with Major Depressive Disorder (MDD) and an inadequate response to antidepressant therapy

Adjunctive Treatment of Major Depressive Disorder

ACADIA Pharmaceuticals Inc.207 participantsStarted Dec 2016

Birmingham, Alabama, United States • Rogers, Arkansas, United States • Garden Grove, California, United States +33 more locations

Treatment of Chronic Stroke With AMES + EMG Biofeedback

A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Find Trials by Condition in Portland

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

World-wide Randomized Antibiotic Envelope Infection Prevention Trial

Acute Care for Elders (ACE) Program at OHSU Hospital

SPRINT - Randomized Trial of Tibial Fracture Fixation

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Study in Subjects With Moderate Atopic Dermatitis

Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease